English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
10 天
信达生物PD-1/IL-2α靶向抗体完成首个关键注册临床研究首例受试者给药
经济观察网讯 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Hits correction territory
Ordered to reinstate workers
CDC nomination withdrawn
Weekly jobless claims fall
Urges US to move nukes
Top FDA lawyer resigns
Smishing scam warning
To host Golden Globes
US influencer sparks outrage
FDA, NIH nominees advance
IRS demotes chief counsel
Ditch new stadium deal
Exits bankruptcy protection
Teixeira pleads guilty
UN report accuses Israel
Trump Tower protest
Marks 12th anniversary
Texas Tech closes campus
States sue to block layoffs
Swatting call about gunman
To test Community Notes
Says he supports ceasefire
Won't block GOP bill
Indonesian fishermen sue
Acne treatments recalled
Won't run for Senate in MI
Police charge stepmother
New moons orbiting Saturn
Out as creative director
反馈